Illumina Revenue 2006-2019 | ILMN

Illumina annual/quarterly revenue history and growth rate from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Illumina revenue for the quarter ending June 30, 2019 was $0.838B, a 0.96% increase year-over-year.
  • Illumina revenue for the twelve months ending June 30, 2019 was $3.405B, a 9.7% increase year-over-year.
  • Illumina annual revenue for 2018 was $3.333B, a 21.11% increase from 2017.
  • Illumina annual revenue for 2017 was $2.752B, a 14.76% increase from 2016.
  • Illumina annual revenue for 2016 was $2.398B, a 8.02% increase from 2015.
Illumina Annual Revenue
(Millions of US $)
2018 $3,333
2017 $2,752
2016 $2,398
2015 $2,220
2014 $1,861
2013 $1,421
2012 $1,149
2011 $1,056
2010 $903
2009 $666
2008 $573
2007 $367
2006 $185
2005 $74
Illumina Quarterly Revenue
(Millions of US $)
Q2 2019 $838
Q1 2019 $846
Q4 2018 $868
Q3 2018 $853
Q2 2018 $830
Q1 2018 $782
Q4 2017 $778
Q3 2017 $714
Q2 2017 $662
Q1 2017 $598
Q4 2016 $619
Q3 2016 $607
Q2 2016 $600
Q1 2016 $572
Q4 2015 $592
Q3 2015 $550
Q2 2015 $539
Q1 2015 $539
Q4 2014 $512
Q3 2014 $481
Q2 2014 $448
Q1 2014 $421
Q4 2013 $387
Q3 2013 $357
Q2 2013 $346
Q1 2013 $331
Q4 2012 $309
Q3 2012 $286
Q2 2012 $281
Q1 2012 $273
Q4 2011 $250
Q3 2011 $235
Q2 2011 $287
Q1 2011 $283
Q4 2010 $261
Q3 2010 $237
Q2 2010 $212
Q1 2010 $192
Q4 2009 $181
Q3 2009 $158
Q2 2009 $162
Q1 2009 $166
Q4 2008 $161
Q3 2008 $150
Q2 2008 $140
Q1 2008 $122
Q4 2007 $113
Q3 2007 $98
Q2 2007 $85
Q1 2007 $72
Q4 2006 $60
Q3 2006 $53
Q2 2006 $42
Q1 2006 $29
Q4 2005 $23
Q3 2005 $20
Q2 2005 $16
Q1 2005 $15
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $44.234B $3.333B
Illumina, Inc. is improving human health by unlocking the power of the genome. Their focus on innovation has established them as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Their products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $117.224B 13.35
Gilead Sciences (GILD) United States $84.245B 10.35
CSL (CSLLY) Australia $72.048B 0.00
Celgene (CELG) United States $69.740B 10.79
Vertex Pharmaceuticals (VRTX) United States $44.966B 48.59
Biogen (BIIB) United States $43.646B 7.75
Regeneron Pharmaceuticals (REGN) United States $30.931B 14.04
Alexion Pharmaceuticals (ALXN) United States $24.082B 12.69
SINO PHARMACEUT (SBMFF) China $17.812B 0.00
Incyte (INCY) United States $16.438B 48.37
Exact Sciences (EXAS) United States $13.817B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.038B 0.00
Genmab (GNMSF) Denmark $12.400B 69.55
Seattle Genetics (SGEN) United States $11.422B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.123B 54.27
Alnylam Pharmaceuticals (ALNY) United States $9.307B 0.00
Galapagos (GLPG) Belgium $8.835B 0.00
QIAGEN (QGEN) Netherlands $7.676B 25.22
Bio-Techne Corp (TECH) United States $7.614B 52.60
Guardant Health (GH) United States $7.205B 0.00
Sarepta Therapeutics (SRPT) United States $6.393B 0.00
BeiGene (BGNE) Cayman Islands $6.372B 0.00
Amarin (AMRN) Ireland $5.969B 0.00
ACADIA Pharmaceuticals (ACAD) United States $5.845B 0.00
Exelixis (EXEL) United States $5.828B 15.15
Bluebird Bio (BLUE) United States $5.795B 0.00
Moderna (MRNA) United States $5.517B 0.00
Horizon Pharma Public (HZNP) Ireland $4.911B 12.48
ARGENX SE-ADR (ARGX) Netherlands $4.760B 0.00
Ascendis Pharma (ASND) Denmark $4.370B 0.00
Repligen (RGEN) United States $4.109B 79.74
Spark Therapeutics (ONCE) United States $4.032B 0.00
China Biologic Products (CBPO) China $3.914B 24.43
Blueprint Medicines (BPMC) United States $3.877B 0.00
Medicines (MDCO) United States $3.790B 0.00
MorphoSys AG (MOR) Germany $3.725B 0.00
Alkermes (ALKS) Ireland $3.504B 0.00
Mirati Therapeutics (MRTX) United States $3.362B 0.00
Immunomedics (IMMU) United States $3.210B 0.00
Emergent Biosolutions (EBS) United States $2.683B 40.31
Genomic Health (GHDX) United States $2.674B 50.15
Reata Pharmaceuticals (RETA) United States $2.607B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.606B 0.00
Arena Pharmaceuticals (ARNA) United States $2.552B 5.48
Ultragenyx Pharmaceutical (RARE) United States $2.544B 0.00
Amicus Therapeutics (FOLD) United States $2.495B 0.00
MyoKardia (MYOK) United States $2.489B 0.00
Halozyme Therapeutics (HALO) United States $2.382B 0.00
Acceleron Pharma (XLRN) United States $2.313B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.253B 0.00
NeoGenomics (NEO) United States $2.218B 118.67
Myriad Genetics (MYGN) United States $2.025B 21.26
Cambrex (CBM) United States $2.007B 25.37
Zai Lab (ZLAB) China $1.973B 0.00
Akcea Therapeutics (AKCA) United States $1.949B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.893B 0.00
Ligand Pharmaceuticals (LGND) United States $1.852B 23.42
Denali Therapeutics (DNLI) United States $1.804B 0.00
UniQure (QURE) Netherlands $1.797B 0.00
Insmed (INSM) United States $1.679B 0.00
Coherus BioSciences (CHRS) United States $1.409B 0.00
REGENXBIO (RGNX) United States $1.396B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.358B 0.00
Alector (ALEC) United States $1.307B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.291B 0.00
Editas Medicine (EDIT) United States $1.263B 0.00
Sangamo Therapeutics (SGMO) United States $1.255B 0.00
RA PHARMCTL INC (RARX) United States $1.208B 0.00
AnaptysBio (ANAB) United States $1.193B 0.00
Fate Therapeutics (FATE) United States $1.172B 0.00
Innoviva (INVA) United States $1.160B 3.35
Epizyme (EPZM) United States $1.089B 0.00
Athenex (ATNX) United States $1.065B 0.00
Zymeworks (ZYME) Canada $1.006B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.999B 0.00
Twist Bioscience (TWST) United States $0.973B 0.00
Cara Therapeutics (CARA) United States $0.933B 0.00
ANI Pharmaceuticals (ANIP) United States $0.926B 15.46
Arvinas (ARVN) United States $0.850B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.843B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.841B 0.00
Codexis (CDXS) United States $0.838B 0.00
Principia Biopharma (PRNB) United States $0.834B 435.13
WAVE Life Sciences (WVE) Singapore $0.821B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.769B 0.00
Anika Therapeutics (ANIK) United States $0.743B 26.30
Zealand Pharma (ZEAL) Denmark $0.742B 8.60
Cytokineticsorporated (CYTK) United States $0.727B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.724B 26.14
Zealand Pharma (ZLDPF) Denmark $0.723B 0.00
Vericel (VCEL) United States $0.708B 0.00
Pharming Group (PHGUF) Netherlands $0.706B 0.00
Intellia Therapeutics (NTLA) United States $0.696B 0.00
Mesoblast (MESO) Australia $0.681B 0.00
DBV Technologies S.A (DBVT) France $0.618B 0.00
MiMedx (MDXG) United States $0.590B 0.00
Revance Therapeutics (RVNC) United States $0.572B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.549B 0.00
Intra-Cellular Therapies (ITCI) United States $0.548B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.542B 0.00
Cellectis S.A (CLLS) France $0.538B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.526B 0.00
Retrophin (RTRX) United States $0.523B 0.00
Heska (HSKA) United States $0.523B 67.70
Precision BioSciences (DTIL) United States $0.496B 0.00
Syros Pharmaceuticals (SYRS) United States $0.487B 0.00
UROGEN PHARMA (URGN) United States $0.484B 0.00
Stemline Therapeutics (STML) United States $0.474B 0.00
PHARMA MAR SA (PHMMF) Spain $0.460B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.448B 0.00
Puma Biotechnology (PBYI) United States $0.440B 0.00
Arcus Biosciences (RCUS) United States $0.432B 0.00
BioDelivery Sciences (BDSI) United States $0.431B 0.00
Agenus (AGEN) United States $0.417B 0.00
CytomX Therapeutics (CTMX) United States $0.410B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.398B 0.00
Bellus Health (BLU) Canada $0.391B 0.00
Protagonist Therapeutics (PTGX) United States $0.389B 0.00
Merus (MRUS) Netherlands $0.381B 0.00
Adverum Biotechnologies (ADVM) United States $0.373B 0.00
Scholar Rock Holding (SRRK) United States $0.366B 0.00
Kadmon Holdings (KDMN) United States $0.363B 0.00
Gritstone Oncology (GRTS) United States $0.351B 0.00
AC Immune SA (ACIU) Switzerland $0.341B 25.25
Prothena (PRTA) Ireland $0.336B 0.00
Theratechnologies (THERF) Canada $0.331B 0.00
Albireo Pharma (ALBO) United States $0.317B 0.00
Avid Bioservices (CDMO) United States $0.315B 0.00
Kindred Biosciences (KIN) United States $0.314B 0.00
Biofrontera AG (BFRA) Germany $0.311B 464.00
Sorrento Therapeutics (SRNE) United States $0.304B 0.00
ADMA Biologics Inc (ADMA) United States $0.303B 0.00
Geron (GERN) United States $0.300B 0.00
Clovis Oncology (CLVS) United States $0.296B 0.00
Prometic Life Sciences (PFSCF) Canada $0.291B 0.00
Dynavax Technologies (DVAX) United States $0.291B 0.00
Starpharma Holdings (SPHRY) Australia $0.285B 0.00
Cellular Biomedicine (CBMG) United States $0.285B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.268B 0.00
Seres Therapeutics (MCRB) United States $0.265B 0.00
MannKind (MNKD) United States $0.260B 0.00
Inovio Pharmaceuticals (INO) United States $0.256B 0.00
PDL BioPharma (PDLI) United States $0.256B 6.59
Senesco Technologies (ELOX) United States $0.255B 0.00
ChromaDex (CDXC) United States $0.254B 0.00
Sutro Biopharma (STRO) United States $0.252B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.249B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.246B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.238B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.238B 0.00
Athersys (ATHX) United States $0.229B 0.00
Spero Therapeutics (SPRO) United States $0.223B 0.00
Compugen (CGEN) Israel $0.217B 0.00
Kamada (KMDA) Israel $0.212B 8.09
Five Prime Therapeutics (FPRX) United States $0.210B 0.00
Affimed (AFMD) Germany $0.202B 0.00
Cue Biopharma (CUE) United States $0.200B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.199B 0.00
EXICURE INC (XCUR) United States $0.198B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.193B 0.00
OSMOTICA PHARM (OSMT) United States $0.190B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.187B 0.00
Arsanis (XFOR) United States $0.186B 0.00
Acorda Therapeutics (ACOR) United States $0.186B 0.00
Enzo Biochem (ENZ) United States $0.175B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.173B 0.00
Emmaus Life Sciences (EMMA) United States $0.169B 0.00
POXEL SA FRANCE (PXXLF) France $0.167B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
XOMA (XOMA) United States $0.164B 0.00
Nicox SA (NICXF) France $0.161B 0.00
Northwest Biotherapeutics (NWBO) United States $0.156B 0.00
Strongbridge Biopharma (SBBP) United States $0.155B 6.36
PHASEBIO PHARMA (PHAS) United States $0.154B 0.00
Cerecor (CERC) United States $0.153B 0.00
Alcobra (ARCT) United States $0.151B 0.00
Novavax (NVAX) United States $0.151B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.151B 0.00
Dyadic (DYAI) United States $0.150B 0.00
Abeona Therapeutics (ABEO) United States $0.146B 0.00
Adocia (ADOCY) France $0.140B 0.00
Aptinyx (APTX) United States $0.135B 0.00
NantKwest (NK) United States $0.133B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Fortress Biotech (FBIO) United States $0.128B 0.00
Menlo Therapeutics (MNLO) United States $0.127B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.126B 0.00
SESEN BIO, INC (SESN) United States $0.114B 0.00
Checkpoint Therapeutics (CKPT) United States $0.108B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.106B 0.00
Aduro Biotech (ADRO) United States $0.103B 0.00
Verastem (VSTM) United States $0.099B 0.00
Celyad SA (CYAD) Belgium $0.099B 0.00
Arbutus Biopharma (ABUS) Canada $0.095B 0.00
Idera Pharmaceuticals (IDRA) United States $0.091B 0.00
Mersana Therapeutics (MRSN) United States $0.089B 0.00
Vaccinex (VCNX) United States $0.089B 0.00
Trevena (TRVN) United States $0.088B 0.00
VTv Therapeutics (VTVT) United States $0.087B 0.00
Selecta Biosciences (SELB) United States $0.086B 0.00
OvaScience (MLND) United States $0.084B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.083B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.083B 0.00
Synlogic (SYBX) United States $0.082B 0.00
Antibe Therapeutics (ATBPF) Canada $0.079B 0.00
Catalyst Biosciences (CBIO) United States $0.078B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.076B 0.00
Liquidia Technologies (LQDA) United States $0.076B 0.00
VBI Vaccines (VBIV) United States $0.074B 0.00
Orgenesis (ORGS) United States $0.073B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.073B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.070B 0.00
NewLink Genetics (NLNK) United States $0.070B 0.00
Curis (CRIS) United States $0.069B 0.00
Pluristem Therapeutics (PSTI) Israel $0.068B 0.00
Applied Genetic Technologies (AGTC) United States $0.067B 36.80
AquaBounty Technologies (AQB) United States $0.065B 0.00
ARAVIVE, INC (ARAV) United States $0.065B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.064B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.062B 0.00
Unum Therapeutics (UMRX) United States $0.060B 0.00
Prima BioMed (IMMP) Australia $0.058B 0.00
AIT Therapeutics (XAIR) United States $0.053B 0.00
Oncobiologics (OTLK) United States $0.050B 0.00
Proteostasis Therapeutics (PTI) United States $0.050B 0.00
Ophthotech (ISEE) United States $0.049B 0.00
Vascular Biogenics (VBLT) Israel $0.046B 0.00
VistaGen Therapeutics (VTGN) United States $0.044B 0.00
VIVUS (VVUS) United States $0.044B 0.00
Evogene (EVGN) Israel $0.042B 0.00
Stellar Biotechnologies (EDSA) Canada $0.041B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.040B 0.00
Organovo Holdings (ONVO) United States $0.037B 0.00
Celsion (CLSN) United States $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.036B 0.00
DiaMedica Therapeutics (DMAC) United States $0.035B 0.00
BIOCARDIA INC (BCDA) United States $0.033B 0.00
Signal Genetics (MGEN) United States $0.030B 0.00
Entera Bio (ENTX) Israel $0.030B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
Clearside Biomedical (CLSD) United States $0.030B 0.00
AEterna Zentaris (AEZS) United States $0.030B 0.00
Alimera Sciences (ALIM) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.028B 9.73
Aerpio Pharmaceuticals (ARPO) United States $0.028B 0.00
Apricus Biosciences (SEEL) United States $0.028B 0.00
Caladrius Biosciences (CLBS) United States $0.026B 0.00
TOCAGEN INC (TOCA) United States $0.025B 0.00
Aytu Bioscience (AYTU) United States $0.024B 0.00
Soligenix (SNGX) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Novogen (KZIA) Australia $0.016B 0.00
Prana Biotechnology (ATHE) Australia $0.016B 0.00
CollPlant Holdings (CLGN) Israel $0.015B 0.00
Novelion Therapeutics (NVLN) Canada $0.015B 0.00
TRACON Pharmaceuticals (TCON) United States $0.015B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
Bionano Genomics (BNGO) United States $0.013B 0.00
Cleveland BioLabs (CBLI) United States $0.012B 0.00
TrovaGene (TROV) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Advaxis (ADXS) United States $0.005B 0.00
Neuralstem (CUR) United States $0.004B 0.00